The DOI matches its Crossref record; 24 of the 27 references it cites were found in a registry or an index.
Treatment and prevention of antibiotic associated diarrhea
Abstract
Mild or severe episodes of antibiotic-associated diarrhea (AAD) are common side effects of antibiotic therapy. The incidence of AAD differs with the antibiotic and varies from 5 to 25%. The major form of intestinal disorders is the pseudomembranous colitis associated with Clostridium difficile which occurs in 10-20% of all AAD. In most cases of AAD discontinuation or replacement of the inciting antibiotic by another drug with lower AAD risk can be effective. For more severe cases involving C. difficile, the treatment of diarrhea requires an antibiotic treatment, with glycopeptides (vancomycin) or metronidazole. Another approach to AAD treatment or prevention is based on the use of non-pathogenic living organisms, capable of re-establishing the equilibrium of the intestinal ecosystem. Several organisms have been used in treatment or prophylaxis of AAD such as selected strains of Lactobacillus acidophilus, L. bulgaricus, Bifidobacterium longum, and Enterococcus faecium. Another biotherapeutic agent, a non-pathogenic yeast, Saccharomyces boulardii has been used. In animal models of C. difficile colitis initiated by clindamycin, animals treated with S. boulardii (at end of vancomycin therapy) had a significant decrease in C. difficile colony-forming units, and of toxin B production. In several clinical randomised trials (versus placebo), S. boulardii has demonstrated its effectiveness by decreasing significantly the occurrence of C. difficile colitis and preventing the pathogenic effects of toxins A and B of C. difficile. It has been shown to be a safe and effective therapy in relapses of C. difficile colitis. A good response has been seen in children with AAD, treated by S. boulardii only. In ICUs prevention of AAD remains based on limitation of antibiotic overuse and spread of C. difficile or other agents of AAD should be prevented by improved hygiene measures (single rooms, private bathrooms for patients, use of gloves and hand washing for personnel). In addition the increasing use of biotherapeutic agents such as S. boulardii should permit the prevention of the major side effect of antibiotics, i.e. AAD in at risk patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia
Bartlett, J. G., Chang, T. W., Gurwith, M., Gorbach, S. L., & Onderdonk, A. B. (1978) · New England Journal of Medicine · doi:10.1056/nejm197803092981003 · Cited by 1,374
McFarland, L. V. (1994) · JAMA · doi:10.1001/jama.1994.03510480037031 · Cited by 862
Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study
Surawicz, C. M., Elmer, G. W., Speelman, P., McFarland, L. V., Chinn, J., & van Belle, G. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)91613-2 · Cited by 570
SUCCESSFUL TREATMENT OF RELAPSING CLOSTRIDIUM DIFFICILE COLITIS WITH LACTOBACILLUS GG
Gorbach, S., Chang, T., & Goldin, B. R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92646-8 · Cited by 467
Castagliuolo, I., Riegler, M. F., Valenick, L. V., LaMont, J. T., & Pothoulakis, C. (1999) · Infection and Immunity · doi:10.1128/iai.67.1.302-307.1999 · Cited by 408
Recurrent Clostridium Difficile Disease: Epidemiology and Clinical Characteristics
McFarland, L. V., Surawicz, C. M., Rubin, M., Fekety, R., Elmer, G. W., & Greenberg, R. N. (1999) · Infection Control and Hospital Epidemiology · doi:10.1086/501553 · Cited by 353
Mechanisms and Management of Antibiotic‐Associated Diarrhea
Hogenauer, C., Hammer, H. F., Krejs, G. J., & Reisinger, E. C. (1998) · Clinical Infectious Diseases · doi:10.1086/514958 · Cited by 348
Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo.
McFarland, L. V., Surawicz, C. M., Greenberg, R. N., Elmer, G. W., Moyer, K. A., Melcher, S. A., Bowen, K., & Cox, J. L. (1995) · PubMed · Cited by 338
Effect ofLactobacillusGG Yoghurt in Prevention of Antibiotic Associated Diarrhoea
Siitonen, S., Vapaatalo, H., Salminen, S., Gordin, A., Saxelin, M., Wikberg, R., & Kirkkola, A.-L. (1990) · Annals of Medicine · doi:10.3109/07853899009147243 · Cited by 326
Elmer, G. W. (1996) · JAMA · doi:10.1001/jama.275.11.870 · Cited by 326
Research works printed but not linked: 5
- Rampal, 1994, Les diarrhées de l'antibiothérapie, Hépatol. Gastrol., 1, 391
- Carbon, 1994, Les colites pseudomembraneuses associées à l'antibiothérapie, Therapie, 49, 325
- Bouhnik, 1993, Utilisation des probiotiques chez l'homme, Ann. Gastroentérol. Hépatol., 29, 241
- Adam J, Barret A, Barret-Bellet L et al. Essais cliniques contrôlés en double insu de l'Ultra-Levure lyophilisée. Etude multicentrique par 25 médecins de 388 cas. Gaz Med France 1977;84:2072–2078.
- Bergogne-Bérézin, 1995, Impact écologique de l'antibiothérapie. Place des microorganismes de substitution dans le contrôle des diarrhées et colites associées aux antibiotiques, Presse Med., 24, 145
Cited by
Sorted by citations
Items 101–173 of 173
Reclamation of Herb Residues Using Probiotics and Their Therapeutic Effect on Diarrhea
Meng, F., Chen, T., Ma, D., Wang, X., Zhao, X., Tian, P., Wang, H., Hai, Z., Shen, L., Tang, X., et al. (2017) · Mediators of Inflammation · doi:10.1155/2017/4265898 · Cited by 10
Synbiotics: promoting gastrointestinal health.
Gupta, C. G. C., Prakash, D. P. D., Rostagno, M. H., & Callaway, T. R. (2014) · CABI eBooks · doi:10.1079/9781780643632.0061 · Cited by 9
Deepak, P., & Ehrenpreis, E. D. (2011) · Disease-a-Month · doi:10.1016/j.disamonth.2011.05.005 · Cited by 9
Protection of dried probiotic bacteria from bile using bile adsorbent resins
Mahbubani, K. T. A., Slater, N. K. H., & Edwards, A. D. (2013) · New Biotechnology · doi:10.1016/j.nbt.2013.09.001 · Cited by 8
Pupaibool, J., Khantipong, M., & Suankratay, C. (2008) · PubMed · Cited by 8
Are Probiotic Effects Dose-Related?
Patton, T. J., & Guandalini, S. (2013) · World review of nutrition and dietetics · doi:10.1159/000345751 · Cited by 7
Antibiotic-associated diarrhoea
Overeem, K., van Soest, G., & Blankenstein, N. (2008) · British Journal of General Practice · doi:10.3399/bjgp08x279959 · Cited by 7
Sefton, A. M. (2004) · Encyclopedia of Gastroenterology · doi:10.1016/b0-12-386860-2/00509-8 · Cited by 7
Wu, M.-Z., Sun, T.-C., Huang, Y.-W., Wu, Y.-C., Chen, W.-J., Chu, H.-F., Liu, C.-Y., & Chau, C. (2022) · Processes · doi:10.3390/pr10102123 · Cited by 6
Probiotics for the Prevention of Antibiotic-Associated Diarrhea
Hicks, C., Moore, S., Andrade, A., Gentry, C., & Taormina, C. (2013) · Kansas Journal of Medicine · doi:10.17161/kjm.v6i4.11460 · Cited by 6
The emerging role of the microbial-gastrointestinal-neural axis
McLean, P. G., Calver, A. R., Alpers, D., Collins, S. M., Shanahan, F., & Lee, K. (2009) · Gastroenterology Insights · doi:10.4081/gi.2009.e3 · Cited by 6
A Case of Pseudomembranous Colitis after Voriconazole Therapy
Kwon, J., Kang, M.-K., Kim, S., Choi, S., Kim, H., Min, W.-S., & Lee, D. (2011) · Yonsei Medical Journal · doi:10.3349/ymj.2011.52.5.863 · Cited by 5
Řehořová, V., Cibulková, I., Soukupova, H., & Duška, F. (2022) · Future Pharmacology · doi:10.3390/futurepharmacol2010005 · Cited by 4
Bakker, J., Klomp, R., Rijnbeek, M. W., Arndt, S. S., Philippens, I. H. C. H. M., & Langermans, J. A. M. (2014) · Animal Biotelemetry · doi:10.1186/2050-3385-2-10 · Cited by 4
Park, S., Kang, D.-H., Seo, H.-S., & Kim, J.-W. (2014) · Herbal Formula Science · doi:10.14374/hfs.2014.22.2.121 · Cited by 4
Acid Tolerance and Fecal Recovery Following Oral Administration ofSaccharomyces cerevisiae
Scevola, D., Perversi, L., Cavanna, C., Candiani, C., Uberti, F., Castiglioni, B., & Marone, P. (2003) · Journal of Chemotherapy · doi:10.1179/joc.2003.15.2.143 · Cited by 4
Mentula, S. (2005) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) · Cited by 3
Clymer, B. C., Daniels, A. M., Smalley, L., Richeson, J. T., & Madere, S. P. (2015) · The Professional Animal Scientist · doi:10.15232/pas.2015-01422 · Cited by 3
Chapter 2 Development of the neonatal microbiota
Young, G. R., Zalewski, S., Cummings, S. P., & Lanyon, C. V. (2017) · Wageningen Academic Publishers eBooks · doi:10.3920/978-90-8686-839-1_2 · Cited by 3
ANTIBIOTIC-ASSOCIATED DIARRHEA IN CHILDREN: PRINCIPLES OF PROPHYLAXIS AND TREATMENT
Черников, В. В., & Сурков, А. Н. (2012) · Вопросы современной педиатрии · doi:10.15690/vsp.v11i2.210 · Cited by 3
Ardestani, S. K., Robinson, J. L., Dieleman, L. A., Huynh, H. Q., Jou, H., & Vohra, S. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024651 · Cited by 3
Chloramphenicol eye drops in the treatment of conditions indicative of maxillary sinusitis
Nielsen, I. R., Seim, A., & Bentzen, N. (2013) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.11.0879 · Cited by 3
Biotherapeutics and biotherapy of surgical enteropathies
Periti, P., & Tonelli, F. (2002) · Digestive and Liver Disease · doi:10.1016/s1590-8658(02)80174-8 · Cited by 3
Muraki, Y., Tanabe, M., Nakamura, A., Matsushima, Y., Senoo, M., Fukuda, M., & Okuda, M. (2010) · Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) · doi:10.5649/jjphcs.36.316 · Cited by 3
Systemische Antibiotikatherapie bei Infektionen im Skelettsystem
Frommelt, L. (2004) · Springer eBooks · doi:10.1007/978-3-642-59302-4_11 · Cited by 3
Intestinal Side Effects of Improper Antibiotic Use
Nikmaram, A. (2022) · Journal of Reports in Pharmaceutical Sciences · doi:10.4103/jrptps.jrptps_108_21 · Cited by 2
Trinh, C. (2007) · Nutrition and disease prevention · doi:10.1201/9781420005493.ch6 · Cited by 2
Weis, S., & Grimm, M. (2011) · Der Internist · doi:10.1007/s00108-010-2789-9 · Cited by 2
Emerging Issues and Trends In Clostridium Difficile Colitis
(2009) · Springer eBooks · doi:10.1007/978-0-387-84841-9_9 · Cited by 2
Diarrea nosocomial por Clostridium difficile en mayores de 80 años
Canovas, C., & Merino-Fernández, F. J. (2005) · Revista Española de Geriatría y Gerontología · doi:10.1016/s0211-139x(05)74831-9 · Cited by 2
Sutradhar, P., Das, M. C., Suna, S. P., Pattanayak, C., Panda, P. S., & Debata, I. (2024) · Cureus · doi:10.7759/cureus.76062 · Cited by 1
Talhi, M., Cornu, B., Mehaya, R. T., Sahraoui, D., Dib, W., Yazi, L., Zemmour, A., OUAHRANI, N. S., Mourad, K., & Wauven, C. V. (2017) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.11.4.15 · Cited by 1
Antibiotikainduzierte Diarrhö und pseudomembranöse Enterokolitis
Greb, C., Kalem, T., & Kälble, T. (2002) · Der Urologe · doi:10.1007/s00120-002-0267-2 · Cited by 1
Choueiry, E., Kamel, R., Chacar, H., Mouawad, P., & Sacy, R. (2017) · International Journal of Clinical Pediatrics · doi:10.14740/ijcp269w · Cited by 1
INABA, Y., Ohyama, Y., Tomomatsu, N., Michi, Y., & YAMAGUCHI, S. (2018) · Japanese Journal of Oral & Maxillofacial Surgery · doi:10.5794/jjoms.64.464 · Cited by 1
Antibiotic use, gastroenteritis and respiratory illness in South Australian children
Talbot-Smith, A., & Heyworth, J. S. (2002) · Epidemiology and Infection · doi:10.1017/s0950268802007628 · Cited by 1
Initiating a practice change: Prescribing probiotics concurrently with antibiotic therapy
Hermosilla, P. (2009) · doi:10.33915/etd.3507 · Cited by 1
Treatment and prevention of antibiotic-associated colitis
Bergogne-Bérézin, E. (2004) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7930-9_4 · Cited by 1
Self-citationTHE FLATULENCE SYMPTOM IN SMALL CHILDREN: CAUSES AND WAYS OF CORRECTION
Surkov, A. N., & Черников, В. В. (2013) · Педиатрическая фармакология · doi:10.15690/pf.v10i1.593
Blanquet, S., & Alric, M. (2010) · Pharmaceutical Sciences Encyclopedia · doi:10.1002/9780470571224.pse354
Surkov, A. N. (2013) · Вопросы современной педиатрии · doi:10.15690/vsp.v12i2.621
Do probiotics have a role in the treatment and prevention of nosocomial infections?
McFarland, L. V. (2005) · Australian Infection Control · doi:10.1071/hi05012
Effects ofSaccharomyces boulardiion antibiotic induced orocecal transit in rats
Duman, D., Akin, H., Deniz, M., Can, G., & Yeğen, B. Ç. (2014) · Acta Alimentaria · doi:10.1556/aalim.43.2014.3.4
Milchsäurebakterien und Gesundheit: Das Anwendungsspektrum von Probiotika bei Erwachsenen
Blum, S. (2005) · Schweizerische Zeitschrift für Ganzheitsmedizin / Swiss Journal of Integrative Medicine · doi:10.1159/000281943
Diarrea por Clostridium difficile en relación con levofloxacino
Pascual, M. V. R., Poza, J. C. V., & Seseña, P. L.-H. (2004) · Medicina de Familia SEMERGEN · doi:10.1016/s1138-3593(04)74327-0
Lei, V., Friis, H., & Michaelsen, K. F. (2015)
ROLE OF PROBIOTICS IN PREVENTION AND TREATMENT OF ANTIBIOTIC-ASSOCIATED DIARRHEA IN CHILDREN
Surkov, A. N. (2014) · Педиатрическая фармакология · doi:10.15690/pf.v11i4.1062
Антибиотик-ассоциированная диарея у детей: принципы профилактики и лечения
Tchernikov, V. V., & Surkov, A. N. (2012) · CyberLeninK (CyberLeninka)
Возможности коррекции и профилактики нарушений микробиоценоза кишечника у часто болеющих детей
Russian Federation (2013) · CyberLeninK (CyberLeninka)
Role of Probiotics in Prevention and Treatment of Antibiotic-Associated Diarrhea in Children
Surkov, A. N., & Russian Federation (2014) · CyberLeninK (CyberLeninka)
Ferguson, B. J., & Duvvuri, U. (2006) · CRC Press eBooks · doi:10.3109/9780849374487-19
Xiang, Y., Wang, Z., Cai, P., & Zhang, Z. (2016) · PubMed Central · doi:10.7499/j.issn.1008-8830.2016.10.017
Chong, K. (2009) · eScholarship@McGill (McGill) · doi:10.82308/33152
Edwards-Marshall, M. (2010) · Journal of International Crisis and Risk Communication Research
McQuade, E. T. R. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/bz63-vs75
Varankovich, N. V. (2017) · University Library - University of Saskatchewan (University of Saskatchewan)
Dietary Impacts on the Composition of Microbiota in Human Health and Disease
Verma, A. K., Kumari, R., Bhattacharya, A., & Paul, J. (2017) · Springer eBooks · doi:10.1007/978-981-10-5708-3_21
Antibiotic - Associated Diarrhoea: Pharmacotherapeutic and Preventive Aspects in Children
Gupte, N. (2017) · Gastroenterology & Hepatology International Journal · doi:10.23880/ghij-16000130
Ferry, G. D., & Versalovic, J. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50056-x
Antimicrobial Treatments of Infectious Diarrhea
Brun, P., & Castagliuolo, I. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00069-4
Shan, J., Yao, S., Shen, Y., Li, X., Ding, H., Zou, W., Xu, Y., Jin, D., & Yang, R. (2021) · Research Square · doi:10.21203/rs.3.rs-842262/v1
Kuhad, A., Kaur, I. P., Chopra, K., & Garg, A. (2009) · CRC Press eBooks · doi:10.1201/9781420062151.ch18
Probiotics in Infectious Diseases
Fong, I. W. (2009) · Springer eBooks · doi:10.1007/978-0-387-84841-9_10
Katelaris, P. (2007) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1098626.553474
Cas pratique : marche à suivre face à une ordonnance comportant un antibiotique
(2014) · Actualités Pharmaceutiques · doi:10.1016/s0515-3700(14)71368-0
Gastrointestinal symptoms of COVID-19 in children
Faltin, K., Małecki, P., Mania, A., Cwalińska, A., Kostrzewa-Faltin, M., Lubarski, K., Lewandowska, Z., Mazur‐Melewska, K., & Figlerowicz, M. (2022) · Pediatria Polska · doi:10.5114/polp.2022.123233
Disboyizisin Önlenmesi ve Sağlıklı Mikrobiyota Gelişimi için Probiyotikler
Çakır, A., Arslan, M., Sadioglu, O. D., Akdemir, T., Az, A., Güven, Ş., Ümit, T. B., Helvaci, M. S., Çalık, M., Coşkun, A., et al. (2024) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3110
Research Progress on Antibiotic-Associated Hemorrhagic Colitis
Zhang, M., & Xu, K. (2025) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2025.1312014
Alam, W., Sheikh, S., Chowdhury, R., Hasan, M. S. A., Eity, T. A., Bhuia, M. S., Oni, M. I. J., Ansari, S. A., Ahammed, N. T., Kamli, H. M., et al. (2026) · Chemical Biology & Drug Design · doi:10.1111/cbdd.70266
Kobeissy, H. (2018) · theses.fr (ABES) · doi:10.70675/f14d613cz28dfz470aza7a6zdbe81a631560
Alhammad, A. (2009) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/90j8-tw61
Metadata
- Authors
- Bergogne-Bérézin, E.
- Affiliations
- Université Paris Diderot (FR)
- Corresponding author
- Bergogne-Bérézin, E
- Venue
- International Journal of Antimicrobial Agents
- Publisher
- Elsevier BV
- Published
- 2000-12
- Volume
- 16
- Issue
- 4
- Pages
- 521-526
- ISSN
- 0924-8579 (ISSN-L)
- OpenAlex
- W2065697342
- Cited by
- 174
- References
- 27
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 4 · 2023: 1 · 2022: 6 · 2021: 7 · 2020: 1 · 2019: 4 · 2018: 8 · 2017: 8 · 2016: 6 · 2015: 5 · 2014: 13 · 2013: 14 · 2012: 8
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Antimicrobial Agents (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- antibiotic-associated diarrhea, Clostridium difficile, pseudomembranous colitis, Saccharomyces boulardii, probiotics, vancomycin, metronidazole, Lactobacillus, Bifidobacterium longum, Enterococcus faecium, clindamycin, antibiotic overuse, infection control, toxin A and B, childhood diarrhea
- MeSH terms
- Anti-Bacterial Agents, Diarrhea, Enterocolitis, Pseudomembranous, Humans, Intestines, Lacticaseibacillus casei, Risk Factors, Saccharomyces, Clostridioides difficile, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review